These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8313336)

  • 1. Insulin-like growth factor II mRNA, peptides, and receptors in a thoracopulmonary malignant small round cell tumor.
    Nielsen FC; Orskov C; Haselbacher G; Ramlau J; Christiansen J; Schmiegelow K; Rehfeld JF
    Cancer; 1994 Feb; 73(4):1312-9. PubMed ID: 8313336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries.
    el-Roeiy A; Chen X; Roberts VJ; Shimasakai S; Ling N; LeRoith D; Roberts CT; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor expression in human cancer cell lines.
    Quinn KA; Treston AM; Unsworth EJ; Miller MJ; Vos M; Grimley C; Battey J; Mulshine JL; Cuttitta F
    J Biol Chem; 1996 May; 271(19):11477-83. PubMed ID: 8626706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC).
    Scharf JG; Schmidt-Sandte W; Pahernik SA; Ramadori G; Braulke T; Hartmann H
    Carcinogenesis; 1998 Dec; 19(12):2121-8. PubMed ID: 9886566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma.
    Kiaris H; Schally AV; Varga JL
    Cancer Lett; 2000 Dec; 161(2):149-55. PubMed ID: 11090963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human rhabdomyosarcoma cell line.
    Nielsen FC; Haselbacher G; Christiansen J; Lake M; Grønborg M; Gammeltoft S
    Mol Cell Endocrinol; 1993 May; 93(1):87-95. PubMed ID: 7686519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
    Noll K; Wegmann BR; Havemann K; Jaques G
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of IGFs and IGFBPs mRNA levels and tissue concentrations in liver, kidney and skeletal muscle of pig.
    Peng M; Pelletier G; Palin MF; Véronneau S; LeBel D; Abribat T
    Growth Dev Aging; 1996; 60(3-4):171-87. PubMed ID: 9007568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues.
    Van der Ven LT; Roholl PJ; Gloudemans T; Van Buul-Offers SC; Welters MJ; Bladergroen BA; Faber JA; Sussenbach JS; Den Otter W
    Br J Cancer; 1997; 75(11):1631-40. PubMed ID: 9184179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata.
    Giudice LC; Irwin JC; Dsupin BA; Pannier EM; Jin IH; Vu TH; Hoffman AR
    Hum Reprod; 1993 Nov; 8(11):1796-806. PubMed ID: 7507128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries.
    Mason HD; Cwyfan-Hughes SC; Heinrich G; Franks S; Holly JM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):276-84. PubMed ID: 8550764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue.
    Neuvians TP; Gashaw I; Hasenfus A; Hacherhäcker A; Winterhager E; Grobholz R
    Neoplasia; 2005 May; 7(5):446-56. PubMed ID: 15967097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture.
    Barreca A; Larizza D; Damonte G; Arvigo M; Ponzani P; Cesarone A; Lo Curto F; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1041-6. PubMed ID: 9100570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA; Moats-Staats BM; Stiles AD
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.
    Hodzic D; Delacroix L; Willemsen P; Bensbaho K; Collette J; Broux R; Lefèbvre P; Legros JJ; Grooteclaes M; Winkler R
    Horm Metab Res; 1997 Nov; 29(11):549-55. PubMed ID: 9479554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
    Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.
    Daughaday WH; Emanuele MA; Brooks MH; Barbato AL; Kapadia M; Rotwein P
    N Engl J Med; 1988 Dec; 319(22):1434-40. PubMed ID: 3185662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.